Removal of access to alemtuzumab for patients with aggressive multiple sclerosis

被引：1
|
作者：
Thompson, Alan J. [1 ]
Giovannoni, Gavin [2 ]
机构：
[1] UCL, UCL Inst Neurol, London WC1N 3BG, England
[2] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2013年 / 346卷
关键词：
CONTROLLED PHASE-3 TRIAL;
D O I：
10.1136/bmj.f275
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Alemtuzumab as Treatment for Multiple Sclerosis
    Katsavos, Serafeim
    Coles, Alasdair
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (10):
  • [32] The Outlook for Alemtuzumab in Multiple Sclerosis
    Williams, Thomas
    Coles, Alasdair
    Azzopardi, Laura
    BIODRUGS, 2013, 27 (03) : 181 - 189
  • [33] FOLLOW UP EXAMINATION OF MULTIPLE SCLEROSIS PATIENTS TREATED WITH ALEMTUZUMAB IN MULTIPLE SCLEROSIS CENTRE, SZEGED
    Fricska-Nagy Zsanett
    Fuvesi Judit
    Kincses Zsigmond Tamas
    Legradi Dora
    Vecsei Laszlo
    Klivenyi Peter
    Bencsik Krisztina
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2022, 75 (11-12): : 377 - 384
  • [34] Subcutaneous administration of alemtuzumab in patients with highly active multiple sclerosis
    Perumal, Jai S.
    Foo, Farng
    Cook, Perry
    Khan, Omar
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (08) : 1197 - 1199
  • [35] Sleep and fatigue features in multiple sclerosis patients on alemtuzumab treatment
    Barun, B.
    Skoric, M. Krbot
    Mioc, M.
    Crnosija, L.
    Adamec, I.
    Mudrovcic, M.
    Milosevic, N.
    Habek, M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 942 - 942
  • [36] Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab
    Saarela, Mika
    Senthil, Keerthi
    Jones, Joanne
    Tienari, Pentti J.
    Soilu-Hanninen, Merja
    Airas, Laura
    Coles, Alasdair
    Saarinen, Jukka T.
    NEUROLOGY, 2018, 90 (18) : 849 - 851
  • [37] Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients
    Ilkka Rauma
    Tiina Mustonen
    Juha Matti Seppä
    Maritta Ukkonen
    Marianne Männikkö
    Auli Verkkoniemi-Ahola
    Marge Kartau
    Jukka T. Saarinen
    Liisa Luostarinen
    Sakari Simula
    Mervi Ryytty
    Riitta Ahmasalo
    Jussi O. T. Sipilä
    Ilkka Pieninkeroinen
    Tero Tapiola
    Anne M. Remes
    Hanna Kuusisto
    Journal of Neurology, 2022, 269 : 824 - 835
  • [38] Alemtuzumab: A Review of Its Use in Patients with Relapsing Multiple Sclerosis
    Garnock-Jones, Karly P.
    DRUGS, 2014, 74 (04) : 489 - 504
  • [39] Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis
    John, Nevin
    Carroll, Antonia
    Brownlee, Wallace J.
    Chataway, Jeremy
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : 1376 - +
  • [40] Alemtuzumab and thyroid dysfunction in patients with Multiple Sclerosis: A case series
    Garrahy, A.
    Ali, S.
    McQuaid, S. E.
    Byrne, M. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S365 - S365
12345